SARS-CoV-2 IgG Antibody Test
The SARS-CoV-2 IgG Antibody Test detects IgG antibodies that develop as an immune response to a prior COVID-19 infection. A positive result confirms past exposure but does not diagnose active illness or detect immunity from vaccination. Doctors use this blood test to evaluate unexplained symptoms, confirm prior infection, and track antibody persistence, providing useful insight into a patient’s history with coronavirus infection.
- $120
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
SARS CoV 2 AB IGG
The SARS-CoV-2 IgG Antibody Test test contains 1 test with 1 biomarker .
SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative
Clinical Significance
SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative - This test is intended as an aid in identifying individuals with antibodies to SARS-CoV-2. A positive result indicates an immune response to a recent or prior infection with SARS-CoV-2. This test would not be expected to detect an immune response to a spike vaccine. It is unknown for how long antibodies persist following infection or if the presence of antibodies confers protective immunity. This assay should not be used to diagnose acute SARS-CoV-2 infection.